Figure 1 compares the total blood levels of IL‐1β (Figure 1A) and IL‐8 (Figure 1B) levels of vitiligo patients with healthy control, then compares the levels of mentioned factors before and after using MEBHQ. This evidence concerns the gene CXCL8 and vitiligo.